Table 5.

Respondents with clinical measurements associated with vascular risk

Blood pressure levels and anti-hypertensive treatment	Percentage (95% CI)
Normal blood pressure, no treatment	57.1% (51.8, 62.3)
High blood pressure, no pharmacological treatment	32.6% (27.8, 37.7)
JNC7 Stage 1 high blood pressure, no pharmacological treatment	17.6% (13.8, 21.9)
JNC7 Stage 2 high blood pressure, no pharmacological treatment	15.0% (11.5, 19.2)
On pharmacological treatment for high blood pressure	10.3% (7.3, 13.9)
Normal blood pressure on pharmacological treatment	5.29% (3.21, 8.14)
JNC7 Stage 1 high blood pressure, on pharmacological treatment	2.79% (1.34, 5.06)
JNC7 Stage 2 high blood pressure, on pharmacological treatment	2.23% (0.967, 4.34)
Lipid profilei
Total cholesterol > 5.0 mmol/l	25.6 (20.4, 31.2)
HDL cholesterol < 1.2 mmol/l	22.2 (17.3, 27.7)
HDL:total cholesterol ≥ 20%ii	93.5 (89.9, 96.2)

ⁱ no-one was using treatment to lower cholesterol levels.

ⁱⁱ excluding 3 men with an HDL cholesterol at or above 3 mmol/l